Marina Parton
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- PARP inhibition in cancer therapy
- Cancer Treatment and Pharmacology
Papers in
-
- Breast Cancer Treatment Studies 19
- Oncology 38
- HER2/EGFR in Cancer Research 20
- Cancer Treatment and Pharmacology 11
- Cancer-related Molecular Pathways 6
- Co-authors
- Ian E. SmithMitch DowsettJanine SalterJorge S. Reis‐FilhoRoger A’HernRobin L. JonesA NerurkarNicholas C. Turner
- Journals
- Breast Cancer Research and Treatment (9 papers)Journal of Clinical Oncology (8 papers)Clinical Cancer Research (3 papers)British Journal of Cancer (3 papers)The Breast (3 papers)
- Partner nations
- United KingdomSpainGermany
In The Last Decade
Marina Parton
46 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 743
- Oncology 955
- Pathology and Forensic Medicine 234
- Pulmonary and Respiratory Medicine 298
- Molecular Biology 577
Countries citing papers authored by Marina Parton
This map shows the geographic impact of Marina Parton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Parton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Parton more than expected).
Fields of papers citing papers by Marina Parton
This network shows the impact of papers produced by Marina Parton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Parton. The network helps show where Marina Parton may publish in the future.
Co-authors
The 25 scholars most cited alongside Marina Parton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 3 | |
| 5 | 2020 | 16 | |
| 6 | 2019 | 1 | |
| 7 | 2018 | 55 | |
| 8 | 2017 | 28 | |
| 9 | 2017 | 1 | |
| 10 | 2016 | 1 | |
| 11 | 2016 | 6 | |
| 12 | 2011 | 20 | |
| 13 | 2010 | 222 | |
| 14 | 2010 | 8 | |
| 15 | 2008 | 234 | |
| 16 | 2003 | 71 | |
| 17 | 2003 | 79 | |
| 18 | Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy. | 2002 | 62 |
| 19 | 2002 | 61 | |
| 20 | 2001 | 130 |
About Marina Parton
Marina Parton is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Genetics and Pathology and Forensic Medicine, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (20 papers), Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (11 papers), Breast Lesions and Carcinomas (9 papers), Advanced Breast Cancer Therapies (7 papers), Cancer-related Molecular Pathways (6 papers), Lung Cancer Treatments and Mutations (6 papers) and BRCA gene mutations in cancer (4 papers). The work is most often cited by research in Cancer Research (743 citations), Oncology (955 citations), Pathology and Forensic Medicine (234 citations), Pulmonary and Respiratory Medicine (298 citations) and Molecular Biology (577 citations). Marina Parton has collaborated with scholars based in United Kingdom, Spain and Germany. Frequent co-authors include Ian E. Smith, Mitch Dowsett, Janine Salter, Jorge S. Reis‐Filho, Roger A’Hern, Robin L. Jones, A Nerurkar, Nicholas C. Turner, Monika Graeser and Margaret Hills. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Clinical Oncology, Clinical Cancer Research, British Journal of Cancer and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.